NCT03325985
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 50 Years and older (Adult, Older Adult)
Location of Metastases: 
Additional Notes: Patients must have health insurance, reside within the geographical area, and have a working telephone
Exclusions: Patients under 50 years of age
https://ClinicalTrials.gov/show/NCT03325985